|
US5318973A
|
|
Neuroprotective composition for preventing or treating of central nervous system impairment
|
|
SK356592A3
|
|
Analgetic drink
|
|
CZ213091A3
|
|
process for preparing 6-chlorophthalide
|
|
CS164891A3
|
|
N-arylalkyl derivatives of 2-aminomethyl-1,4-benzodioxan, and process forpreparing thereof
|
|
CS164791A3
|
|
Process for preparing ergoline derivatives
|
|
CS142691A3
|
|
Process for preparing 5-//4-/(4',6'-dimethyl-2-pyrimidinyl)sulfamoyl/phenyl/azo/-acetylsalicylic acid
|
|
CS659990A3
|
|
Process for preparing crystalline 3,4-dimethyl-phenyl-n-d-ribitylamine
|
|
CS650190A3
|
|
Process for preparing n-chlorophthalimide
|
|
CS600990A3
|
|
Bicyclo (2,2,1)hept-5-ene-3-carboxy-2-carboxamides and bicyclo(2,2,1)hept-7-oxa-5-ene-3-carboxy-2-carboxamides and process for preparingthereof
|
|
CS567590A3
|
|
Fluoroquinolone derivatives having in the position 7 4-piperidone radical or modifications thereof
|
|
CS513590A3
|
|
Process for preparing hydantoin-5-spirocyclopentane
|
|
CS513490A3
|
|
Process for preparing cyclo(l-alanyl-1-amino-1-cyclopentanecarbonyl)
|
|
CS513190A3
|
|
Process for preparing 1-amino-1-cyclopentanecarboxylic acid
|
|
CS513390A3
|
|
Process for preparing methylsuccinic acid anhydride
|
|
CS513290A3
|
|
Process for preparing hydrochloride of 1-amino-1-cyclopentanecarboxylic acid methyl ester
|
|
CZ478590A3
|
|
Process for preparing 2-/3-carbamoyl-3,3-diphenylpropyl/-1-methylpiperidinium bromide
|
|
CS364090A3
|
|
3-phenyl-3-(1-naphthylthio) propylamines and 3-(1-naphthylthio)-3-(2-thienyl) propylamines
|
|
CS328590A3
|
|
N,n-dimethyl-2-/2-thyenylthio/ benzyl amines
|
|
CS328690A3
|
|
N,n-dimethyl-(arylthio)thenylamines
|
|
CS302690A3
|
|
Process for preparing 2,2-diphenyl-4-piperidine butanenitrile
|
